Carmona A - Search Results

1

Design of a score to identify hospitalized patients at risk of drug-related problems.

Urbina O, Ferrández O, Grau S, Luque S, Mojal S, Marin-Casino M, Mateu-de-Antonio J, Carmona A, Conde-Estévez D, Espona M, González E, Riu M, Salas E. Urbina O, et al. Among authors: carmona a. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10. Pharmacoepidemiol Drug Saf. 2014. PMID: 24817497

2

[Enfuvirtide: first drug of a new family of antiretroviral agents].

Espona M, Ferrández O, Grau S, Carmona A. Espona M, et al. Among authors: carmona a. Farm Hosp. 2005 Nov-Dec;29(6):375-83. doi: 10.1016/s1130-6343(05)73699-0. Farm Hosp. 2005. PMID: 16433570 Review. Spanish.

3

Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count.

Knobel H, Guelar A, Montero M, Carmona A, Luque S, Berenguer N, González A. Knobel H, et al. Among authors: carmona a. HIV Med. 2008 Jan;9(1):14-8. doi: 10.1111/j.1468-1293.2008.00513.x. HIV Med. 2008. PMID: 18199168 Free article.

4

Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.

Knobel H, Urbina O, González A, Sorlí ML, Montero M, Carmona A, Guelar A. Knobel H, et al. Among authors: carmona a. HIV Med. 2009 Jul;10(6):364-9. doi: 10.1111/j.1468-1293.2009.00696.x. Epub 2009 Mar 11. HIV Med. 2009. PMID: 19490179 Free article.

5

Monitoring of antimicrobial therapy by an integrated computer program.

Grau S, Monterde J, Carmona A, Drobnic L, Salas E, Marín M, Campany D, Mateu J. Grau S, et al. Among authors: carmona a. Pharm World Sci. 1999 Aug;21(4):152-7. doi: 10.1023/a:1008610912290. Pharm World Sci. 1999. PMID: 10483602

6

Ritonavir-induced carbamazepine toxicity.

Mateu-de Antonio J, Grau S, Gimeno-Bayón JL, Carmona A. Mateu-de Antonio J, et al. Among authors: carmona a. Ann Pharmacother. 2001 Jan;35(1):125-6. doi: 10.1345/aph.10039. Ann Pharmacother. 2001. PMID: 11197575 No abstract available.

7

Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.

Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, Saballs P, Gimeno JL, Díez A. Knobel H, et al. Among authors: carmona a. AIDS Patient Care STDS. 2001 Apr;15(4):193-9. doi: 10.1089/10872910151133729. AIDS Patient Care STDS. 2001. PMID: 11359661

8

Adherence and effectiveness of highly active antiretroviral therapy.

Knobel H, Carmona A, Grau S, Pedro-Botet J, Díez A. Knobel H, et al. Among authors: carmona a. Arch Intern Med. 1998 Sep 28;158(17):1953. doi: 10.1001/archinte.158.17.1953. Arch Intern Med. 1998. PMID: 9759698 No abstract available.

9

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.

Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, Kindelan JM, Carmona A, Juega J, Ocampo A; GEEMA Study Group. Knobel H, et al. Among authors: carmona a. AIDS. 2002 Mar 8;16(4):605-13. doi: 10.1097/00002030-200203080-00012. AIDS. 2002. PMID: 11873004

10

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.

García de Olalla P, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA. García de Olalla P, et al. Among authors: carmona a. J Acquir Immune Defic Syndr. 2002 May 1;30(1):105-10. doi: 10.1097/00042560-200205010-00014. J Acquir Immune Defic Syndr. 2002. PMID: 12048370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters